Christopher Ware - Concepedia

Concepedia

Author

Christopher Ware

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Christopher M. Ware, Christopher Ware, Jagdeep Bather, Ware, Christopher

47

Publications

1.1K

Citations

11

H-Index

38

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy The University of Texas Southwestern Medical Center University of Michigan Harvard University

CW

About

Christopher Ware is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in cell biology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	474
2	Cell Biology	5	5	474
3	Engineering	1	1	222
4	Social Sciences	1	1	140
5	Cellular Physiology	1	1	140

Christopher Ware

×

11

Publications

1.1K

Citations

11

H-Index

	Year	Citations
Global trends and scenarios for terrestrial biodiversity and ecosystem services from 1900 to 2050 Henrique M. Pereira, Inês S. Martins, Isabel M.D. Rosa, Science Biodiversity LossBiodiversityEngineeringExtensive Model IntercomparisonBiodiversity Assessment	2024	222
Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis Elisa Benedettini, Lynette M. Sholl, Michael Peyton, American Journal Of Pathology Met ActivationMedicineBrain MetastasisPathologyDe Novo Resistance	2010	182
Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma Valeria R. Fantin, Andrey Loboda, Cloud P. Paweletz, Cancer Research	2008	169
Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration Matthew J. Elrick, Chris D. Pacheco, Ting Yu, Human Molecular Genetics Cell DeathNpc1 DeficiencyCellular NeurobiologyCellular PhysiologySocial Sciences	2009	140
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model Kathleen Cullion, Kyle Draheim, Nicole Hermance, Blood	2009	137
Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model Clay L. Efferson, Christopher T. Winkelmann, Christopher Ware, Cancer Research Signaling PathwayEndocrine-related CancerMedicineCancer GrowthGlucose Uptake	2010	92
A Quantitative Volumetric Micro-Computed Tomography Method to Analyze Lung Tumors in Genetically Engineered Mouse Models Brian B. Haines, Kimberly A. Bettano, Mélissa Chénard, Neoplasia	2009	49
FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival Anjili Mathur, Christopher Ware, Lenora J. Davis, PLoS ONE PathologyCancer BiologyTumor BiologyReceptor Tyrosine KinaseCancer Cell Biology	2014	45
Apolipoprotein E genotype and neurological disease onset in Niemann–Pick disease, type C1 Rao Fu, Nicole M. Yanjanin, Matthew J. Elrick, American Journal of Medical Genetics Part A	2012	44
Human Alzheimer’s disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology Sarah M. Rothman, Keith Q. Tanis, Pallavi Gandhi, Journal of Neuroinflammation	2018	41

Page 1